Download Files:
CDD3506
SKU
HY-100902-10 mg
Category Reference compound
Tags Cytochrome P450, Metabolic Disease, Metabolic Enzyme/Protease
$180 – $1,560
Products Details
Product Description
– CDD3506 is used for elevating high density lipoprotein cholesterol (HDL) by inducing hepatic cytochrome P450IIIA (CYP3A) activity.
Web ID
– HY-100902
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C22H19N3
References
– [1]Method for increasing HDL cholesterol levels?using?heteroaromatic phenylmethanes. United States Patent 6103733
CAS Number
– 197913-15-8
Molecular Weight
– 325.41
Compound Purity
– 98.03
SMILES
– NC1=CN(C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)C=N1
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease
Solubility
– DMSO : 19 mg/mL (ultrasonic)
Target
– Cytochrome P450
Isoform
– CYP3
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.